Departamento de Gastroenterologia - FM/MGT
Coleções desta comunidade
Novos documentos depositados
Management of biliary stones in bariatric surgery
THERAPEUTIC ADVANCES IN GASTROINTESTINAL ENDOSCOPY, v.15, article ID 26317745221105000, 12p, 2022
Morbidly obese and post-bariatric surgery patients are at increased risk for biliary stones formation. The complications related to biliary stones may impose complexity on their management. This study aimed to review the management of biliary conditions in obese and bariatric patients. In this st...
RESULTS OF SURGICAL TREATMENT OF COLORECTAL CANCER, ELECTIVE AND EMERGENCY, IN PATIENTS WITH COVID-19
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, v.35, n.1, article ID e1644, 4p, 2022
Non-invasive methods for iron overload evaluation in dysmetabolic patients
ANNALS OF HEPATOLOGY, v.27, n.4, article ID 100707, 8p, 2022
Introduction: Although hyperferritinemia may reflect the inflammatory status of patients with non-alcoholic fatty liver disease (NAFLD), approximately 33% of hyperferritinemia cases reflect real hepatic iron overload. Aim: To evaluate a non-invasive method for assessing mild iron overload in pati...
Administration of an Anal Bulking Agent With Polyacrylate-Polyalcohol Copolymer Particles Versus Endoanal Electrical Stimulation With Biofeedback for the Management of Mild and Moderate Anal Incontinence: A Randomized Prospective Study
DISEASES OF THE COLON & RECTUM, v.65, n.7, p.917-927, 2022
BACKGROUND: There are few treatment options for mild-to-moderate anal incontinence with isolated internal anal sphincter defects or anal incontinence without muscle damage. Less-invasive techniques are generally favored. OBJECTIVE: To compare the results between the use of an anal bulking agent w...
Gastrectomy for elderly gastric cancer patients: A propensity score-matching analysis
JOURNAL OF SURGICAL ONCOLOGY, v.126, n.1, p.108-115, 2022
Background Although D2-gastrectomy is the most effective treatment for resectable gastric cancer (GC), it is unclear whether elderly patients have increased risk of morbidity and worse survival. This study aimed to compare the short- and long-term outcomes of older age (OA) patients with those of...
Sorafenib reduces steatosis-induced fibrogenesis in a human3Dco-culture model of non-alcoholic fatty liver disease
ENVIRONMENTAL TOXICOLOGY, v.36, n.2, p.168-176, 2021
Non-alcoholic fatty liver disease (NAFLD) affects around 25% of the worldwide population. Non-alcoholic steatohepatitis (NASH), the more progressive variant of NAFLD, is characterized by steatosis, cellular ballooning, lobular inflammation, and may culminate on hepatic stellate cell (HSC) activat...
Status of bariatric endoscopy-what does the surgeon need to know? A review
WORLD JOURNAL OF GASTROINTESTINAL SURGERY, v.14, n.2, p.185-199, 2022
BACKGROUND & nbsp;Obesity is a chronic and multifactorial disease with a variety of potential treatment options available. Currently, there are several multidisciplinary therapeutic options for its management, including conservative, endoscopic, and surgical treatment.& nbsp;AIM & nbsp;To clarify...
Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region
TRANSPLANT INTERNATIONAL, v.34, n.1, p.97-109, 2021
This study aimed to compare liver transplantation (LT) outcomes and evaluate the potential rise in numbers of LT candidates with hepatocellular carcinoma (HCC) of different allocation policies in a high waitlist mortality region. Three policies were applied in two Latin American cohorts (1085 HCC...
Preoperative chemotherapy is a better strategy than upfront surgery in cT4 gastric cancer
JOURNAL OF SURGICAL ONCOLOGY, v.126, n.1, p.132-138, 2022
Background Chemotherapy (CMT) followed by surgery is recommended by Western countries for advanced gastric cancer (GC). However, cT4 GC usually undergoes upfront surgery, due to symptoms. This study aimed to evaluate if preoperative CMT is a better strategy than upfront surgery in cT4 GC. Methods...
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis
DIGESTIVE DISEASES AND SCIENCES, v.67, n.7, p.3305-3312, 2022
Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease in which anti-mitochondrial antibodies (AMA) are the diagnostic hallmark. Whether AMA-negative PBC patients represent a different phenotype of disease is highly debated. Aims The purpose of our study was to compar...